In patients with Cystic Fibrosis, recurrent airway infection caused by Pseudomonas aeruginosa
ultimately leads to chronic airway infection. The purpose of this study is to determine
whether supplementary low-dose azithromycin to standard inhaled colistin and oral
ciprofloxacin in the treatment of intermittent pseudomonas airway-infection can postpone the
next episode of intermittent pseudomonas airway-infection and prevent development of chronic
airway-infection.
Phase:
Phase 4
Details
Lead Sponsor:
Rigshospitalet, Denmark
Collaborators:
Cystic Fibrosis Foundation Cystic Fibrosis Foundation Therapeutics